Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon’s perspective

Tumor-infiltrating lymphocytes (TILs) are produced by resecting tumor tissue and growing and expanding ex vivo large quantities of autologous T cells. Once the TILs are ready for infusion, the patient undergoes a non-myeloablative lympho-depleting course of chemotherapy and subsequent TIL infusion w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: ZIPPEL, DOUGLAS B., BESSER, MICHAL, SHAPIRA, RONI, BEN-NUN, ALON, GOITEIN, DAVID, DAVIDSON, TIMA, TREVES, ABRAHAM J., MARKEL, GAL, SCHACHTER, JACOB, PAPA, MOSHE Z.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2012
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438746/
https://ncbi.nlm.nih.gov/pubmed/22969990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.498
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller